Nomura Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-4,920
Closed -$486K – 931
2017
Q3
$486K Hold
4,920
– – 0.01% 826
2017
Q2
$498K Hold
4,920
– – 0.01% 821
2017
Q1
$568K Hold
4,920
– – 0.01% 800
2016
Q4
$591K Hold
4,920
– – 0.01% 797
2016
Q3
$553K Hold
4,920
– – 0.01% 795
2016
Q2
$610K Hold
4,920
– – 0.01% 764
2016
Q1
$553K Buy
4,920
+600
+14% +$62.3K 0.01% 781
2015
Q4
$470K Hold
4,320
– – 0.01% 793
2015
Q3
$431K Hold
4,320
– – 0.01% 811
2015
Q2
$493K Hold
4,320
– – 0.01% 805
2015
Q1
$451K Buy
4,320
+100
+2% +$10.7K 0.01% 822
2014
Q4
$508K Sell
4,220
-260
-6% -$34.2K 0.01% 793
2014
Q3
$656K Hold
4,480
– – 0.01% 708
2014
Q2
$748K Sell
4,480
-350
-7% -$62.3K 0.01% 668
2014
Q1
$958K Hold
4,830
– – 0.02% 576
2013
Q4
$922K Hold
4,830
– – 0.02% 585
2013
Q3
$817K Sell
4,830
-670
-12% -$104K 0.02% 614
2013
Q2
$834K Buy
+5,500
New +$779K 0.02% 608

Other funds holding CLB

Nomura Asset Management's CLB Position: Q4 2017 in Review

Nomura Asset Management sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 4,920 shares — an estimated $486K sold.

Nomura Asset Management first reported a position in CLB in Q2 2013 and held it in 18 quarters. The position peaked at $958K in Q1 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Nomura Asset Management reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Nomura Asset Management sold 4,920 Core Laboratories shares in Q4 2017, an estimated $486K.
  • Nomura Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 18 quarters.
  • Nomura Asset Management's Core Laboratories position peaked at $958K in Q1 2014.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Nomura Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.